top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Journal of gastrointestinal oncology
Journal of gastrointestinal oncology
Pubbl/distr/stampa [Hong Kong], : Pioneer Bioscience Publishing Company, ©2010-
Soggetto topico Gastrointestinal system - Cancer
Gastrointestinal Neoplasms
Soggetto genere / forma Periodicals.
Soggetto non controllato Physiology
ISSN 2219-679X
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Altri titoli varianti JGO
J gastrointest oncol
Record Nr. UNINA-9910140993703321
[Hong Kong], : Pioneer Bioscience Publishing Company, ©2010-
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Journal of gastrointestinal oncology
Journal of gastrointestinal oncology
Pubbl/distr/stampa [Hong Kong], : Pioneer Bioscience Publishing Company, ©2010-
Soggetto topico Gastrointestinal system - Cancer
Gastrointestinal Neoplasms
Soggetto genere / forma Periodicals.
Soggetto non controllato Physiology
ISSN 2219-679X
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Altri titoli varianti JGO
J gastrointest oncol
Record Nr. UNISA-996203946303316
[Hong Kong], : Pioneer Bioscience Publishing Company, ©2010-
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Translational lung cancer research
Translational lung cancer research
Pubbl/distr/stampa [Hong Kong] : , : Pioneer Bioscience Publishing Company, , [2012]-
Descrizione fisica 1 online resource
Disciplina 616.9940072
Soggetto topico Lungs - Cancer
Cancer - Research
Soggetto genere / forma Periodicals.
Fulltext
Internet Resources.
Periodical
ISSN 2226-4477
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Nota di contenuto Something in need is something indeed -- EGFR-TKIs in EGFR-mutated lung cancer: Setting the new standard for 1st line therapy -- Advances on EGFR mutation for lung cancer -- Angiogenesis in cancer: Anti-VEGF escape mechanisms -- Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? -- Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review -- Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy? -- Cetuximab in non-small-cell lung cancer -- Chemotherapy of lung cancer: A global perspective of the role of ifosfamide -- Multi-targeted tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an era of individualized therapy -- Functional CT imaging techniques for the assessment of angiogenesis in lung cancer -- Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis -- Conflict-Management within clinical and administrative stakeholders in medical structures -- Status quo and prospects of the translational research on lung cancer in China.
Altri titoli varianti Transl. lung cancer res.
TLCR
Record Nr. UNINA-9910134870803321
[Hong Kong] : , : Pioneer Bioscience Publishing Company, , [2012]-
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Translational lung cancer research
Translational lung cancer research
Pubbl/distr/stampa [Hong Kong] : , : Pioneer Bioscience Publishing Company, , [2012]-
Descrizione fisica 1 online resource
Disciplina 616.9940072
Soggetto topico Lungs - Cancer
Cancer - Research
Soggetto genere / forma Periodicals.
Fulltext
Internet Resources.
Periodical
ISSN 2226-4477
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Nota di contenuto Something in need is something indeed -- EGFR-TKIs in EGFR-mutated lung cancer: Setting the new standard for 1st line therapy -- Advances on EGFR mutation for lung cancer -- Angiogenesis in cancer: Anti-VEGF escape mechanisms -- Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? -- Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review -- Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy? -- Cetuximab in non-small-cell lung cancer -- Chemotherapy of lung cancer: A global perspective of the role of ifosfamide -- Multi-targeted tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an era of individualized therapy -- Functional CT imaging techniques for the assessment of angiogenesis in lung cancer -- Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis -- Conflict-Management within clinical and administrative stakeholders in medical structures -- Status quo and prospects of the translational research on lung cancer in China.
Altri titoli varianti Transl. lung cancer res.
TLCR
Record Nr. UNISA-996200345203316
[Hong Kong] : , : Pioneer Bioscience Publishing Company, , [2012]-
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui